World's Best Scientists 2026 revealed!
VIEW LIST
Giulio C. Spagnoli

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 75 2016 1846 52 43 331 16006

Giulio C. Spagnoli publications per year

The chart shows the history of publications by Giulio C. Spagnoli between 1984 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Giulio C. Spagnoli published across 42 years, from 1984 to 2025, averaging 9.5 papers a year. Output peaked at 63 publications in 2023. 7 of the 398 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1984 to 2025. Vertical axis: number of publications, 0 to 63. Peak 63 publications in 2023. 1984: 1 publication 1985: 1 publication 1986: 1 publication 1987: 5 publications 1988: 2 publications 1989: 4 publications 1990: 7 publications 1991: 4 publications 1992: 2 publications 1993: 9 publications 1994: 8 publications 1995: 5 publications 1996: 8 publications 1997: 10 publications 1998: 7 publications 1999: 5 publications 2000: 13 publications 2001: 8 publications 2002: 12 publications 2003: 9 publications 2004: 7 publications 2005: 14 publications 2006: 16 publications 2007: 11 publications 2008: 13 publications 2009: 9 publications 2010: 17 publications 2011: 13 publications 2012: 15 publications 2013: 13 publications 2014: 17 publications 2015: 14 publications 2016: 8 publications 2017: 14 publications 2018: 8 publications 2019: 4 publications 2020: 6 publications 2021: 5 publications 2022: 3 publications 2023: 63 publications 2024: 4 publications 2025: 3 publications
1984 2025

398 publications in total across all disciplines

View publications per year as a table
Giulio C. Spagnoli: publications per year, 1984 to 2025
Year Publications
1984 1
1985 1
1986 1
1987 5
1988 2
1989 4
1990 7
1991 4
1992 2
1993 9
1994 8
1995 5
1996 8
1997 10
1998 7
1999 5
2000 13
2001 8
2002 12
2003 9
2004 7
2005 14
2006 16
2007 11
2008 13
2009 9
2010 17
2011 13
2012 15
2013 13
2014 17
2015 14
2016 8
2017 14
2018 8
2019 4
2020 6
2021 5
2022 3
2023 63
2024 4
2025 3
Total 398
Download as CSV

Giulio C. Spagnoli publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Giulio C. Spagnoli sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 322–331 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 331 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97 331
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Giulio C. Spagnoli D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Giulio C. Spagnoli sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 74–75 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133 75
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Giulio C. Spagnoli is affiliated with the University Hospital of Basel in Switzerland. Their work focuses primarily on the fields of Medicine, Immunology, and Microbiology, with particular emphasis on Oncology and Immunology as leading subfields. This specialization includes contributions to Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine.

The main research topics addressed by Giulio C. Spagnoli encompass Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, and Immunotherapy and Immune Responses. Additional focal areas include Cancer Cells and Metastasis, CAR-T cell therapy research, T-cell and B-cell Immunology, and Cancer-related molecular mechanisms research.

The scientist has published extensively, with notable appearances in the following venues:

  • Cancers
  • Preprints.org
  • Nephrology Dialysis Transplantation
  • Scientific Reports
  • Cancer Immunology Research

Frequent collaborators include Giuseppe Sconocchia, Raoul A. Droeser, Benjamin Weixler, Luigi Terracciano, and Giandomenica Iezzi.

Key recent papers authored or coauthored by Giulio C. Spagnoli include:

  • Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches, 2020, Nephrology Dialysis Transplantation
  • Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression, 2021, Scientific Reports
  • Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer, 2020, Cancer Immunology Research
  • Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells, 2022, Cancers
  • Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis, 2020, Frontiers in Medicine

Best Publications

  • Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

    Raoul A. Droeser;Raoul A. Droeser;Christian Hirt;Christian Hirt;Carsten T. Viehl;Daniel M. Frey

  • Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.

    Andreas Mackensen;Birgit Herbst;Ji-Li Chen;Gabriele Köhler

  • Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study

    Sourabh Ghosh;Giulio C. Spagnoli;Ivan Martin;Sabine Ploegert

  • Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

    A Lugli;G Iezzi;I Hostettler;M G Muraro

  • IFN-α2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells

    Elisabetta Padovan;Giulio C. Spagnoli;Maria Ferrantini;Michael Heberer

  • Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11

    Simona Manici;Tiziana Sturniolo;Maria Adele Imro;Juergen Hammer

  • Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

    Tobias Schatton;Ute Schütte;Natasha Y. Frank;Qian Zhan

  • Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.

    A Funaro;G C Spagnoli;C M Ausiello;M Alessio

  • Gut microbiota modulate T cell trafficking into human colorectal cancer

    Eleonora Cremonesi;Valeria Governa;Jesus Francisco Glaus Garzon;Valentina Mele

  • Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro

    Ciara Bocelli-Tyndall;L. Bracci;G. Spagnoli;A. Braccini

  • Genes encoding tumor-specific antigens are expressed in human myeloma cells

    N. Van Baren;F. Brasseur;D. Godelaine;G. Hames

  • Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

    Ulrich Guller;Paul Zajac;Annelies Schnider;Beatrix Bösch

  • The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer.

    valeria governa;Emanuele Trella;Valentina Mele;Luigi Tornillo

  • Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells

    Philipp Müller;Kea Martin;Sebastian Theurich;Jens Schreiner

  • Identification and Intracellular Location of MAGE-3 Gene Product

    Thomas Kocher;Elke Schultz-Thater;Fred Gudat;Christoph Schaefer

  • NK cells and T cells cooperate during the clinical course of colorectal cancer

    Giuseppe Sconocchia;Serenella Eppenberger;Giulio C Spagnoli;Luigi Tornillo

  • Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.

    Evgeny Yakirevich;Edmond Sabo;Ofer Lavie;Salam Mazareb

  • Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.

    A. Alcover;C. Alberini;O. Acuto;L. K. Clayton

  • New dimensions in tumor immunology: what does 3D culture reveal?

    Chantal Feder-Mengus;Sourabh Ghosh;Sourabh Ghosh;Anca Reschner;Ivan Martin

  • CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

    A Lugli;E Karamitopoulou;I Panayiotides;P Karakitsos

  • The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes.

    Urs Lüscher;Luis Filgueira;Antonio Juretic;Markus Zuber

Frequent Co-Authors

Michael Heberer
Michael Heberer University Hospital of Basel
Luigi Terracciano
Luigi Terracciano University Hospital of Basel
Ivan Martin
Ivan Martin University Hospital of Basel
Inti Zlobec
Inti Zlobec University of Bern
Alessandro Lugli
Alessandro Lugli University of Bern
Soldano Ferrone
Soldano Ferrone Harvard University
Achim A. Jungbluth
Achim A. Jungbluth Memorial Sloan Kettering Cancer Center
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
Fabio Malavasi
Fabio Malavasi University of Turin
Francesco Zorzato
Francesco Zorzato University of Ferrara

External Links

Personal website of Giulio C. Spagnoli

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology-related healthcare fields, exploring online nursing degrees can be an excellent pathway. Programs like the fnp to acnp bridge program online offer specialized training for Family Nurse Practitioners looking to transition into Acute Care roles, a skill set valuable in immunology patient care.

Accelerated nursing programs are another popular option, especially for those eager to enter the healthcare workforce quickly. The nurse practitioner accelerated program provides a fast-tracked route to becoming a nurse practitioner, combining rigorous training with flexible online formats.

For individuals without a nursing background but interested in healthcare, online pathways like online adn programs for non nurses can facilitate entry into nursing roles, laying a strong foundation for immunology-related positions.

Many students also seek programs that balance quality with accessibility. Options such as the easiest absn programs to get into allow learners to gain a Bachelor of Science in Nursing efficiently, creating opportunities to specialize further in immunology or related healthcare fields.

Best Scientists Citing Giulio C. Spagnoli

Lloyd J. Old

Lloyd J. Old

Ludwig Cancer Research

Publications: 52

Fabio Malavasi

Fabio Malavasi

University of Turin

Publications: 50

Yao-Tseng Chen

Yao-Tseng Chen

Cornell University

Publications: 49

Achim A. Jungbluth

Achim A. Jungbluth

Memorial Sloan Kettering Cancer Center

Publications: 49

Antonio Cassone

Antonio Cassone

University of Siena

Publications: 40

Ivan Martin

Ivan Martin

University Hospital of Basel

Publications: 35

Ellis L. Reinherz

Ellis L. Reinherz

Harvard University

Publications: 33

Inti Zlobec

Inti Zlobec

University of Bern

Publications: 32

Alessandro Lugli

Alessandro Lugli

University of Bern

Publications: 31

Margot Zöller

Margot Zöller

Heidelberg University

Publications: 28

Sacha Gnjatic

Sacha Gnjatic

Icahn School of Medicine at Mount Sinai

Publications: 27

Pierre van der Bruggen

Pierre van der Bruggen

Université Catholique de Louvain

Publications: 27

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 26

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 25

Daniel E. Speiser

Daniel E. Speiser

University of Lausanne

Publications: 23

Alexander Knuth

Alexander Knuth

University of Zurich

Publications: 23

Trending Scientists

Wen-li Wu

Wen-li Wu

National Institute of Standards and Technology

Joseph H. Harrison

Joseph H. Harrison

Washington State University

Claire M. Fraser

Claire M. Fraser

University of Maryland, Baltimore

Weihua Gui

Weihua Gui

Central South University

Eric E. Mamajek

Eric E. Mamajek

California Institute of Technology

Fumio Tatsuoka

Fumio Tatsuoka

Tokyo University of Science

Lise Appels

Lise Appels

KU Leuven

Jalal Al-Muhtadi

Jalal Al-Muhtadi

King Saud University

Evangelos A. Theodorou

Evangelos A. Theodorou

Georgia Institute of Technology

Michael Bowker

Michael Bowker

Cardiff University

Ian Milsom

Ian Milsom

University of Gothenburg

Eoin O'Brien

Eoin O'Brien

University College Dublin

Michael Koss

Michael Koss

ETH Zurich

Carolyn S.P. Lam

Carolyn S.P. Lam

National University of Singapore

Samantha L. L. Hill

Samantha L. L. Hill

World Conservation Monitoring Centre

Raymundo Arroyave

Raymundo Arroyave

Texas A&M University

Related Immunology Rankings & Guides

2027 Best Direct-Entry NP Programs for Non-Nurses

2027 Best Direct-Entry NP Programs for Non-Nurses
2027 Accelerated Online MPH Programs

2027 Accelerated Online MPH Programs
2027 Best LPN Programs in Florida – Accredited Online LPN Programs

2027 Best LPN Programs in Florida – Accredited Online LPN Programs
2027 Best Accelerated BSN to PhD Online Bridge Programs

2027 Best Accelerated BSN to PhD Online Bridge Programs
2027 Best Accelerated Paramedic to RN Online Bridge Programs

2027 Best Accelerated Paramedic to RN Online Bridge Programs
2027 Best LPN Programs in Kansas – Accredited Online LPN Programs

2027 Best LPN Programs in Kansas – Accredited Online LPN Programs
2027 Best Accelerated Online Nurse Executive Leadership MSN Programs

2027 Best Accelerated Online Nurse Executive Leadership MSN Programs
2027 Best Medical Transcription Courses Online

2027 Best Medical Transcription Courses Online
2027 Best LPN Programs in Pennsylvania – Accredited Online LPN Programs

2027 Best LPN Programs in Pennsylvania – Accredited Online LPN Programs
2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs

2027 Best LPN Programs in Minnesota – Accredited Online LPN Programs
2027 Best LPN Programs in Ohio – Accredited Online LPN Programs

2027 Best LPN Programs in Ohio – Accredited Online LPN Programs
2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs

2027 Best LPN Programs in Connecticut – Accredited Online LPN Programs
2027 Best ADN Nursing Programs in Texas: Online & Campus

2027 Best ADN Nursing Programs in Texas: Online & Campus
2027 Best Accelerated Online MSN/MBA Dual Degree Programs

2027 Best Accelerated Online MSN/MBA Dual Degree Programs
2027 Best Accelerated Online Master of Health Administration (MHA) Programs

2027 Best Accelerated Online Master of Health Administration (MHA) Programs
2027 Best Accelerated LPN/LVN to BSN Online Bridge Programs

2027 Best Accelerated LPN/LVN to BSN Online Bridge Programs
2027 Best Fast-Track RN to BSN Online Programs

2027 Best Fast-Track RN to BSN Online Programs
2027 Best Master’s in Medical Science Programs

2027 Best Master’s in Medical Science Programs
2027 Best LVN Programs in California – Accredited Online LVN Programs

2027 Best LVN Programs in California – Accredited Online LVN Programs
2027 Best Accelerated Online Master’s Programs in Nutrition

2027 Best Accelerated Online Master’s Programs in Nutrition
2027 Best LPN Programs in Tennessee – Accredited Online LPN Programs

2027 Best LPN Programs in Tennessee – Accredited Online LPN Programs

Recently Published Articles

2027 How Much Does a Fine Arts Degree Program Cost? Tuition, Fees & Total Expense Breakdown

2027 How Much Does a Fine Arts Degree Program Cost? Tuition, Fees & Total Expense Breakdown
2027 Online Machine Learning Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Machine Learning Doctorate Programs for Experienced Professionals Without Research Backgrounds
2027 How to Become a Building Inspector: Education, Salary, and Job Outlook

2027 How to Become a Building Inspector: Education, Salary, and Job Outlook
2027 Online Healthcare Management Doctorate Programs for Experienced Professionals Without Research Backgrounds

2027 Online Healthcare Management Doctorate Programs for Experienced Professionals Without Research Backgrounds
2027 How to Become an Art Teacher in New Mexico: Requirements & Certification

2027 How to Become an Art Teacher in New Mexico: Requirements & Certification
2027 What Can You Do with a General Psychology Master's Degree? Careers, Salaries & Growth

2027 What Can You Do with a General Psychology Master's Degree? Careers, Salaries & Growth
2027 Grand Canyon University Online MS in Business Analytics: Cost, Curriculum, Admissions, and Career Outcomes

2027 Grand Canyon University Online MS in Business Analytics: Cost, Curriculum, Admissions, and Career Outcomes
2027 Online Pediatric Nurse Practitioner Degree Programs Costs: Tuition & Fees

2027 Online Pediatric Nurse Practitioner Degree Programs Costs: Tuition & Fees
2027 Theology Degree Jobs That Do Not Require Licensure

2027 Theology Degree Jobs That Do Not Require Licensure
2027 What You Need to Know About Becoming a Nursing Major

2027 What You Need to Know About Becoming a Nursing Major
2027 Supply Chain Management Degree Programs That Accept Transfer Credits

2027 Supply Chain Management Degree Programs That Accept Transfer Credits
2027 Online General Studies Degree Programs Costs: Tuition & Fees

2027 Online General Studies Degree Programs Costs: Tuition & Fees
2027 How Fast Can You Get an Architecture Degree Online?

2027 How Fast Can You Get an Architecture Degree Online?
2027 How to Become a Substance Abuse Counselor in Baltimore, MD: Requirements & Certification

2027 How to Become a Substance Abuse Counselor in Baltimore, MD: Requirements & Certification
2027 Is a General Psychology Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is a General Psychology Master's Degree Worth It? ROI, Salary & Career Impact
2027 Cheapest Online Energy Policy Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Energy Policy Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 Best Online MSN in Clinical Nurse Leadership Programs

2027 Best Online MSN in Clinical Nurse Leadership Programs
2027 Best Nursing Schools in Colorado – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Colorado – Accredited ADN, BSN, MSN Programs
2027 Military-Friendly Online Nutrition Degree Programs: Benefits, Accreditation, and Career Outcomes

2027 Military-Friendly Online Nutrition Degree Programs: Benefits, Accreditation, and Career Outcomes
2027 Most Affordable Online Philosophy Degree Programs

2027 Most Affordable Online Philosophy Degree Programs
2027 Are Online Patient Safety & Quality Degrees Respected by Employers?

2027 Are Online Patient Safety & Quality Degrees Respected by Employers?